Molecular mechanisms underlying chemopreventive potential of curcumin: Current challenges and future perspectives

Life Sciences
Gaurav KumarHardeep S Tuli

Abstract

In recent years, natural compounds have received considerable attention in preventing and curing most dreadful diseases including cancer. The reason behind the use of natural compounds in chemoprevention is associated with fewer numbers of side effects than conventional chemotherapeutics. Curcumin (diferuloylmethane, PubMed CID: 969516), a naturally occurring polyphenol, is derived from turmeric, which is used as a common Indian spice. It governs numerous intracellular targets, including proteins involved in antioxidant response, immune response, apoptosis, cell cycle regulation and tumor progression. A huge mass of available studies strongly supports the use of Curcumin as a chemopreventive drug. However, the main challenge encountered is the low bioavailability of Curcumin. This extensive review covers various therapeutic interactions of Curcumin with its recognized cellular targets involved in cancer treatment, strategies to overcome the bioavailability issue and adverse effects associated with Curcumin consumption.

References

Jan 1, 1996·Genes & Development·E White
Mar 3, 1999·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Y AbeT Horie
Sep 30, 2000·Japanese Journal of Cancer Research : Gann·J UshidaH Mori
Oct 19, 2000·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·S E ChuangM L Kuo
Jul 20, 2002·The Journal of Pharmacology and Experimental Therapeutics·Rajinder K BhardwajMartin F Fromm
Sep 26, 2002·Journal of Biochemistry and Molecular Biology·Seong-Su HanYoung-Joon Surh
Oct 3, 2002·Biochemical and Biophysical Research Communications·Anupama E GururajBharathi P Salimath
Apr 8, 2003·Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer·Subrata RayAmitava Chatterjee
Oct 15, 2003·The Journal of Pharmacology and Experimental Therapeutics·Po-Yung ChengEdward T Morgan
Mar 11, 2004·Journal of Enzyme Inhibition and Medicinal Chemistry·Carmen Martín-CorderoMaria Jesús Ayuso
Apr 2, 2004·Nature Reviews. Cancer·Mary Ann Jordan, Leslie Wilson
May 15, 2004·Cancer Letters·G Radhakrishna PillaiEwa Carrier
Jun 24, 2004·Nature Reviews. Genetics·Lin He, Gregory J Hannon
Sep 11, 2004·Biochemical and Biophysical Research Communications·Eun-Ryeong HahmChul-Hak Yang
Oct 27, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ricky A SharmaWilliam P Steward
Nov 22, 2005·Life Sciences·Sophie P ValentineRhonda J Rosengren
Jan 4, 2006·Prostate Cancer and Prostatic Diseases·J H HongH Y Choi
Feb 8, 2006·Proceedings of the National Academy of Sciences of the United States of America·Stefano VoliniaCarlo M Croce
Feb 14, 2006·American Journal of Physiology. Gastrointestinal and Liver Physiology·Dongmei YeThomas Y Ma

❮ Previous
Next ❯

Citations

Jul 13, 2016·European Journal of Pharmacology·Guddadarangavvanahally K JayaprakashaBhimanagouda S Patil
Jul 23, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Dharambir KashyapAnil K Sharma
Jul 23, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Dharambir KashyapHardeep Singh Tuli
Nov 9, 2016·Maturitas·Raúl Baena Ruiz, Pedro Salinas Hernández
Nov 15, 2016·Expert Review of Anticancer Therapy·Nisha Durand, Peter Storz
Dec 21, 2017·Medical Sciences : Open Access Journal·Tracy Murray-Stewart, Robert A Casero
Jan 18, 2018·International Journal of Molecular Sciences·Ana M L Seca, Diana C G A Pinto
Nov 1, 2017·Antioxidants & Redox Signaling·Jan F StevensClaudia S Maier
Jun 9, 2018·Pharmaceutical Patent Analyst·Priya YadavR Srinivas
Sep 20, 2019·International Journal of Molecular Sciences·Patricia Rodríguez CastañoAmit V Pandey
May 31, 2017·Current Medicinal Chemistry·José TeixeiraPaulo J Oliveira
Feb 29, 2020·Antioxidants·Emiliano PanieriLuciano Saso
Sep 12, 2016·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Dong ChenWenbin Chen
Jul 12, 2017·BioMed Research International·Jingquan LinXuehong Liu
Dec 11, 2019·Nutrients·Wan Nur Baitty Wan Mohd TajuddinRakesh Naidu
May 11, 2018·Oxidative Medicine and Cellular Longevity·Marzena WojcikLucyna Alicja Wozniak
Nov 6, 2020·Journal of Ovarian Research·Mohammad Hossein PourhanifehHamed Mirzaei
Feb 14, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Hardeep Singh TuliAnupam Bishayee
Mar 7, 2021·Pharmaceuticals·Paula Garcia-OliveiraMiguel Angel Prieto

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Related Papers

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
Gaurav KumarSardul S Sandhu
Current Drug Targets
Hongyu ZhouShile Huang
Frontiers in Bioscience (Scholar Edition)
Beatrice E BachmeierAndreas G Nerlich
Archives of Physiology and Biochemistry
Leelavinothan PariJuergen Eckel
World Journal of Gastrointestinal Pathophysiology
Sigrid A Rajasekaran
© 2022 Meta ULC. All rights reserved